ArticlePloS one2026
Elucidating the mechanistic association of xylene inducing non-small cell lung cancer through network toxicology and molecular docking analysis.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Xylene is a common industrial solvent that includes three isomers: o-xylene, m-xylene, and p-xylene. Long-term exposure to low doses of xylene in the environment has been linked to a higher risk of lung cancer. However, the molecular mechanisms behind this link are still not fully understood. In this study, we used a combination of network toxicology and molecular docking to investigate how xylene may contribute to the development of non-small cell lung cancer (NSCLC). We first identified 115 potential target genes related to xylene exposure by searching several public databases, including CHEMBL, STITCH, GeneCards, and OMIM. Further screening using the STRING platform and Cytoscape analysis highlighted five core targets: IL1A, H3C13, ITGAM, CCR5, and COMT. We utilized scRNA-seq data to analyze the expression patterns of core targets across distinct cell subpopulations, the majority of core targets were expressed in immune cells. We then performed GO and KEGG pathway enrichment analysis. These results showed that the five target genes are mainly involved in cancer-related pathways, such as ECM-receptor interaction, focal adhesion, chemical carcinogenesis, and the PI3K-Akt signaling pathway. Molecular docking results confirmed that xylene isomers have strong binding affinities with the proteins encoded by these genes. This suggests that xylene may disrupt important cellular signals and promote tumor growth. In conclusion, our study provides new insight into how xylene might cause NSCLC at the molecular level. It also shows the usefulness of network toxicology in evaluating health risks from environmental chemicals. These findings may help guide future efforts in prevention and treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.